Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-01-24 @ 6:26 PM
Study NCT ID:
NCT02257359
Status:
COMPLETED
Last Update Posted:
2018-09-13
First Post:
2014-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-18
Start Date Type:
ACTUAL
Primary Completion Date:
2015-01-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01-29
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-02
First Submit QC Date:
None
Study First Post Date:
2014-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-11
Last Update Post Date:
2018-09-13
Last Update Post Date Type:
ACTUAL